bromo < bromocriptine < bromocryptin

Facettes :

List of bibliographic references indexed by bromocriptine

Number of relevant bibliographic references: 18.

Ident.	Authors (with country if any)	Title
000B50 (2009)	Louis C. S. Tan [Singapour] ; Kenneth K. C. Ng [Singapour] ; Wing-Lok Au [Singapour] ; Raymond K. K. Lee [Singapour] ; Yiong-Huak Chan [Singapour] ; Nigel C. K. Tan [Singapour]	Bromocriptine use and the risk of valvular heart disease
001185 (2006)	Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France]	The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease
001843 (2002)	Robert A. Hauser [États-Unis] ; Nicholas H. G. Holford [Nouvelle-Zélande]	Quantitative description of loss of clinical benefit following withdrawal of levodopa–carbidopa and bromocriptine in early Parkinson's disease
001B64 (2000)	Claudia Ramaker [Pays-Bas] ; Willem Johan T. Van De Beek [Pays-Bas] ; Martijn J. J. Finken [Pays-Bas] ; Bob J. J. Van Hilten [Pays-Bas]	The efficacy and safety of adjunct bromocriptine therapy for levodopa‐induced motor complications: A systematic review
001F13 (1998)	Ronald K. B. Pearce [Royaume-Uni] ; Tara Banerji [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni]	De novo administration of ropinirole and bromocriptine induces less dyskinesia than L‐dopa in the MPTP‐treated marmoset
002129 (1996)	J. Boas [Danemark] ; J. Worm-Petersen [Danemark] ; E. Dupont [Danemark] ; B. Mikkelsen [Danemark] ; L. Wermuth [Danemark]	The levodopa dose‐sparing capacity of pergolide compared with that of bromocriptine in an open‐label, crossover study
002187 (1996)	H. Przuntek ; D. Welzel [Allemagne] ; M. Gerlach ; E. Blümner [Allemagne] ; W. Danielczyk [Autriche] ; -J. Kaiser ; H. Kraus ; H. Letzel [Allemagne] ; P. Riederer ; K. Überla [Allemagne]	Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study
002315 (1995)	E. R. P. Brunt [Pays-Bas] ; M. J. Boeree [Pays-Bas]	Low dose bromocriptine‐induced pleural effusion and pleuropulmonary fibrosis
002550 (1993)	Factor [États-Unis] ; William J. Weiner [États-Unis]	Early combination therapy with bromocriptine and levodopa in parkinson's disease
002644 (1992)	H. Przuntek [Allemagne] ; D. Welzel [Allemagne] ; E. Blümner [Allemagne] ; W. Danielczyk [Autriche] ; H. Letzel [Allemagne] ; -J. Kaiser [Allemagne] ; H. Kraus [Allemagne] ; P. Riederer [Allemagne] ; D. Schwarzmann [Allemagne] ; H. Wolf [Allemagne] ; K. Überla [Allemagne]	Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued
002769 (1990)	B. Bergamasco [Italie] ; P. Benna [Italie] ; L. Scarzella [Italie]	Long‐term bromocriptine treatment of de novo patients with Parkinson's disease. A seven‐year follow‐up
002A15 (1985)	Yasuo Toyokura ; Yoshikuni Mizuno ; Masao Kase ; Itsuro Sobue ; Yoshigoro Kuroiwa ; Hirotaro Narabayashi ; Masanori Uono ; Takao Nakanishi ; Masakuni Kameyama ; Hitoshi Ito ; Yasuo Shimada ; Makoto Iwata	Effects of bromocriptine on Parkinsonism A nation‐wide collaborative double‐blind study
002A92 (1983)	Lieberman [États-Unis] ; Govindan Gopinathan [États-Unis] ; Andreas Neophytides [États-Unis] ; Morton Leibowitz [États-Unis] ; Russell Walker [États-Unis] ; Emil Hiesiger [États-Unis]	Bromocriptine and lisuride in Parkinson disease
002B18 (1982)	E. Schneider [Allemagne] ; -A. Fischer [Allemagne]	Long-term experience with bromocriptine in advanced parkinsonism
002B28 (1982)	Kurt Jellinger [Autriche]	Adjuvant treatment of parkinson's disease with dopamine agonists: Open trial with bromocriptine and CU 32-085
002B40 (1981)	R. Glantz [États-Unis] ; G. Goetz [États-Unis] ; A. Nausieda [États-Unis] ; J. Weiner [États-Unis] ; L. Klawans [États-Unis]	The effect of bromocriptine (BCT) on the on-off phenomenon
002B52 (1981)	Margaret M. Hoehn [États-Unis]	Bromocriptine and Its Use in Parkinsonism
002C12 (1978)	Rinne [Finlande] ; R. Marttila [Finlande]	Brain dopamine receptor stimulation and the relief of parkinsonism: Relationship between bromocriptine and levodopa

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "bromocriptine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "bromocriptine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    bromocriptine
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024